• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Clal Biotechnology

edit

Clal Biotechnology Industries Ltd (CBI) is the largest biotechnology investment group in Israel. CBI targets promising companies with innovative bio-pharma technologies and transforms them into thriving and productive businesses.

Recent Milestones

edit

• 
  Clal Biotechnology invested in Avraham Pharmaceuticals. (2/21/13)
  Posted 2/21/13 at 7:20pm via finsmes.com
• 
  Clal Biotechnology invested in Gamida Cell. (5/15/12)
  Posted 5/15/12 at 6:10pm via finsmes.com
• 
  Clal Biotechnology invested in Avraham Pharmaceuticals. (11/14/11)
  Posted 11/14/11 at 6:44pm via finsmes.com
• 
  Clal Biotechnology invested in Avraham Pharmaceuticals. (7/13/10)
  Posted 7/13/10 at 5:33pm via onbiovc.com
• 
  Clal Biotechnology invested in ProtAb. (4/23/10)
  Posted 4/23/10 at 7:40pm via co.il
• 
  Clal Biotechnology invested in Aposense. (8/20/08)
  Posted 6/22/09 at 9:44pm via equityhelpdesk.com
• 
  Clal Biotechnology invested in Polyheal. (1/1/07)
  Posted 3/19/10 at 10:19pm via ivc-online.com

Investments

Videos

Sources

1. Avraham Pharmaceuticals Raises $ 5.7M in Funding (finsmes.com) [edit]
2. Gamida Cell Closes $10m Series E Financing (finsmes.com) [edit]
3. Avraham Pharmaceuticals Closes $3M Financing (finsmes.com) [edit]
4. Avraham Pharmaceuticals, Ltd.: Series A $9M (onbiovc.com) [edit]
5. ProtAb has recently raised $4M from HBL and two of the largest life science venture capital firms in Israel, (hbl.co.il) [edit]
6. Aposense Adds $7.3 Million (equityhelpdesk.com) [edit]
7. Wound management co Polyheal raises $1m (ivc-online.com) [edit]